Article

Pharmacy Quiz: Test Your Knowledge on Alzheimer Disease

Author(s):

Saro Arakelians, PharmD

Ten quiz questions to assess your knowledge on common symptoms and treatments for Alzheimer disease.

True or false: Alzheimer disease is a progressive neurologic disorder that causes the brain to shrink and have atrophy, and brain cells to die.


Related Videos
California Wildfire, Pharmacy, Community | Image Credit: Erin | stock.adobe.com
Allergies, Asthma, Biologic Treatment, Pharmacists | Image Credit: Pixel-Shot | stock.adobe.com
Woman professional nutritionist checking dietary supplements in hand, surrounded by a variety of fruits, nuts, vegetables, and dietary supplements on the table - Image credit: amenic181 | stock.adobe.com
Related Content
Walgreens, Opioids, Controlled Substance Act, False Claims Act | Image Credit: Timon | stock.adobe.com
January 20th 2025

US Court Files Civil Complaint Alleging Walgreens Dispensed Millions of Unlawful Prescriptions

Ashley Gallagher, Editor
Public Health Matters: The Importance of Reproductive Justice and Black Maternal Health
December 24th 2024

Public Health Matters: The Importance of Reproductive Justice and Black Maternal Health

Christina M. Madison, PharmD, FCCP, AAHIVP
FDA US Food and Drug website in browser with company logo | Image Credit: © Postmodern Studio - stock.adobe.com
January 17th 2025

FDA’s Accelerated Approval Pathway Under Scrutiny for Key Drug Approvals

Alexandra Gerlach, Associate Editor
Pharmacy Focus: Oncology Edition – Key Insights and Interviews From the 2024 SABCS Meeting
December 23rd 2024

Pharmacy Focus: Oncology Edition – Key Insights and Interviews From the 2024 SABCS Meeting

Alexandra Gerlach, Associate Editor
Doctor or physician recommend pills medical prescription to male Patient hospital and medicine concept - Image credit: joyfotoliakid | stock.adobe.com
January 17th 2025

The Evolving Business Model of Pharmacy: Moving Beyond Dispensing

Anjeza Fero, PharmD, RPh
Blood sample testing for hepatitis B virus -- Image credit: gamjai | stock.adobe.com
January 17th 2025

Xalnesiran Plus Immunomodulator Results in HBsAg Loss Among Patients With Chronic Hepatitis B

Gillian McGovern, Associate Editor